THE FIRST EXPERIENCE OF USAGE OF POSITRON EMISSION TOMOGRAPHY WITH “C-CHOLINE IN PROSTATE CANCER (PC)
Vol. 70 No. 2 (2024), Articles
Vol. 70 No. 2 (2024)

THE FIRST EXPERIENCE OF USAGE OF POSITRON EMISSION TOMOGRAPHY WITH “C-CHOLINE IN PROSTATE CANCER (PC)

Articles
https://doi.org/10.37469/0507-3758-2013-59-4-460-464
Published 15.12.2013
Russian Research Center of Radiology and Surgical Technologies
Russian Research Center of Radiology and Surgical Technologies
Russian Research Center of Radiology and Surgical Technologies
Russian Research Center of Radiology and Surgical Technologies
Russian Research Center of Radiology and Surgical Technologies
Russian Research Center of Radiology and Surgical Technologies
Russian Research Center of Radiology and Surgical Technologies
Russian Research Center of Radiology and Surgical Technologies
Russian Research Center of Radiology and Surgical Technologies
Russian Research Center of Radiology and Surgical Technologies
Russian Research Center of Radiology and Surgical Technologies
Russian Research Center of Radiology and Surgical Technologies
Russian Research Center of Radiology and Surgical Technologies
Russian Research Center of Radiology and Surgical Technologies
Russian Research Center of Radiology and Surgical Technologies
##article.numberofdownloads## 54
##article.numberofviews## 68
PDF (Русский)

Keywords

prostate cancer
PET-CT with “C-choline
biochemical relapse

How to Cite

, , , , , , , , , , , , , , & . (2013). THE FIRST EXPERIENCE OF USAGE OF POSITRON EMISSION TOMOGRAPHY WITH “C-CHOLINE IN PROSTATE CANCER (PC). Voprosy Onkologii, 70(2), 460–464. https://doi.org/10.37469/0507-3758-2013-59-4-460-464
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Abstract

Introduction into clinical practice of combined positron emission technology and computer tomography (PET / CT) allows in one study to identify structural and functional abnormalities. The study involves 32 patients who underwent PET / CT with “C-choline, including 5 patients with prostate cancer (PC), 3 — with chronic prostatitis and 24 — with biochemical PC recurrence. PET / CT with “C-choline has a high diagnostic efficacy in detection of local recurrence and PC metastases in patients with biochemical PC recurrence. The results of visual analysis do not permit to distinguish PC from benign prostate diseases.
https://doi.org/10.37469/0507-3758-2013-59-4-460-464
##article.numberofdownloads## 54
##article.numberofviews## 68
PDF (Русский)

References

Aus G., Abbou C.C., Pacik D. et al. EAU guidelines on prostate cancer // Europ. Urol. — 2001. — Vol. 40. — P. 97-101

Boccon-Gibod L., Djavan W.B., Hammerer P. et al. Management of prostate-specific antigen relapse in prostate cancer: a European Consensus // Int J Clin Pract. — 2004. — Vol. 58. — P. 382-390.

Castellucci P., Fuccio C., Nanni C., et al. Influence of trigger PSA and PSA kinetics on 11C-choline PET / CT detection rate in patients with biochemical relapse after radical prostatectomy // J. Nucl. Med. — 2009. — Vol. 50. — P. 1394-1400.

Cher M.L., Bianco F.J. Jr., Lam J.S. et al. Limited role of radionu-clide bone scintigraphy in patients with prostate specific anti-gen elevations after radical prostatectomy // J Urol. — 1998. — Vol. 160. — P. 387-91.

Choueiri T.K., Dreicer R., Paciorek A. et al. A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial de-finitive local therapy // Ibid. — 2008. — Vol. 179. — P. 906-910

Farsad M., Schiavina R., Castellucci P. et al. Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis // J Nucl Med. — 2005. — Vol. 46. — P. 1642-1649.

Giovacchini G., Picchio M., Coradeschi E. et al. Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy // Europ J Nucl Med Mol Imaging. — 2010. — Vol. 37. — P. 301-309.

Giovacchini G., Picchio M., Coradeschi E., et al. [(11)C] choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy // Ibid. — 2008. — Vol. 35. — P. 1065-1073.

Giovacchini G., Picchio M., Scattoni V. et al. PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy // Ibid. — 2010. — Vol. 37. — P. 1106-1116.

Gomez P., Manoharan M., Kim S.S., Soloway M.S. Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated? // BJU Int. — 2004. — Vol. 94. — P. 299-302.

Heidenreich A., Bastian P.J., Bellmunt J. et al. Prostate cancer // EAU guidelines. — 2013. — P. 114 — 125.

Moul J.W. Prostate specific antigen only progression of prostate cancer // J Urol. — 2000. — Vol. 163 — P. 1632-1642.

Okotie O.T., Aronson W.J., Wieder J.A.et al. Predictors of metastatic disease in men with biochemical failure following radical prostatectomy // Ibid. — 2004. — Vol. 171. — P. 2260-2261.

Picchio M., Briganti А., Fanti S. et al. The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer // Europ Urol. — 2011. — Vol. 59. — P. 51-60.

Reske S.N., Blumstein N.M., Glatting G. [11C]choline PET/CT imagingin occult local relapse of prostate cancer after radical prostatectomy // Europ J Nucl Med Mol Imaging. — 2008. — Vol. 35. — P. 9-17.

Richter J.A., Rodriguez M., Rioja J. et al. Dual tracer (11) C-choline and FDG-PET in the diagnosis of biochemical prostate cancer relapse after radical treatment // Mol Imaging Biol. — 2010. — Vol. 12. — P. 210-217.

Roach III M., Hanks G., Thames Jr. H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference // Int J Radiat Oncol Biol Phys. — 2006. — Vol. 65. — P. 965-974.

Scattoni V., Picchio M., Suardi N., et al. Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy // Europ Urol. — 2007. — Vol. 52. — P. 423-429.

Scher B., Seitz M., Albinger W. et al. Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer // Europ J Nucl Med Mol Imaging. — 2007. — Vol. 34. — P. 45-53.

Schwarzenbock S., Souvatzoglou M., Krause B.J. Choline PET and PET/CT in primary diagnosis and staging of prostate cancer // Theranostics. — 2012. — Vol. 2. — P. 318-330.

All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...